Global clinical trials activity decreases 2.9% in Q2 2020
Global clinical trials activity decreased by 2.9% in Q2 2020, when compared with the same quarter in 2019, according to…
Latest Clinical Trials Analysis
-
2 months
-
2 months
-
2 months
-
6 months
-
2 months
-
2 months
-
2 months
-
6 months
Europe accounts for 18.7% share of global clinical trial activity in 2019
Europe accounted for an 18.7% of global clinical trials activity in 2019, a decrease of 7.6% compared with a 26.3%…
Latest News
View More
WHO’s Solidarity trial shows repurposed drugs for Covid-19 are ineffective
World Health Organization (WHO) has reported that interim data from the Solidarity Therapeutics Trial of remdesivir, hydroxychloroquine, lopinavir / ritonavir and interferon regimens showed the…
Janssen Tremfya shows higher skin clearance rates in plaque psoriasis trial
The Janssen Pharmaceutical Companies of Johnson & Johnson has reported that open-label extension data from Phase III VOYAGE 1 trial of Tremfya (guselkumab) showed high…
Sanofi and Translate Bio find positive preclinical Covid-19 vaccine results
Sanofi’s vaccines global business unit Sanofi Pasteur and Translate Bio have reported preclinical trial results that showed mRNA-based vaccine candidate,…
Evelo Biosciences concludes patient enrolment in atopic dermatitis drug trial
Biotech firm Evelo Biosciences has completed enrolment of 24 patients in the Phase Ib EDP1815-101 trial cohort of investigational oral…
Astex trials of guadecitabine for leukaemia fail to meet primary end point
Astex Pharmaceuticals has reported that Phase III trials of guadecitabine (sSGI-110) failed to meet the primary endpoint of improving overall…
Bayer’s Aliqopa provides prolonged progression-free survival in iNHL trial
Bayer has reported that the Phase III CHRONOS-3 trial of Aliqopa (copanlisib) in combination with rituximab to treat patients with…
Latest Content
View MoreSIMPONI ARIA (golimumab) for the Treatment of Polyarticular Juvenile Idiopathic Arthritis (pJIA)
SIMPONI ARIA® (golimumab) is a fully human anti-tumour necrosis factor (TNF) alpha monoclonal antibody. It is indicated for the treatment…
SOM Biotech Announces Poster Presentation on the Repurposing of Eravacycline for the Treatment of SARS-CoV-2
SOM Biotech, a biopharmaceutical company specialising in the repositioning of existing drugs for the treatment of diseases with a high…
How the Formedix Visual Define.xml Editor Gives You Faster Define
Define.xml is the metadata that describes the content and formatting of submission datasets and the case report tabulation data. It’s…
In Vivo Pharmacology and PK/PD Testing of Novel Therapeutics Webinar
Noble Life Sciences is pleased to announce that it will be hosting In Vivo Pharmacology and PK/PD Testing of Novel…